Medical News

RSS

FDA approves Avastin plus interferon-alfa for people with metastatic renal cell carcinoma

Genentech, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Avastin (bevacizumab) plus interferon-alfa for people with metastatic renal cell carcinoma, the most common type of kidney cancer. According to the American Cancer Society, kidney cancer is the eighth most commonly diagnosed cancer in the United States. In 2009, approximately 13,000 Americans will die from the disease.

3 Aug 2009

US FDA approves Lipsovir for cold sores

The US Food and Drug Administration (FDA) has now approved Lipsovir, i.e. granted Medivir's New Drug Application (NDA) for the use of acyclovir and hydrocortisone for early treatment of recurrent cold sores to decreases the risk of cold sores, and to shorten the healing time for those cold sores which are not prevented.

3 Aug 2009

Seven out of ten U.S. children low in vitamin D

Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.

3 Aug 2009

Anti-growth factor drugs raise hope and concern for treatment of children's eye diseases

A new class of antibody drugs may provide a powerful new tool for the treatment of eye diseases in children, but specialists need to be alert for the possibility of serious side effects, according to an editorial in the August Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus), published by Elsevier.

3 Aug 2009

Research may bring powerful new test for inflammatory lung diseases

Chronic inflammatory lung diseases like chronic bronchitis and emphysema are a major global health problem, and the fourth leading cause of death and disability in developed countries, with smoking accounting for 90% of the risk for developing them.

3 Aug 2009

FDA approves Invega Sustenna for schizophrenia

The U.S. Food and Drug Administration today approved Invega Sustenna (paliperidone palmitate) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adults.

2 Aug 2009

FDA approves Onglyza (saxagliptin) for type 2 diabetes

The U.S. Food and Drug Administration has approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to be used with diet and exercise to control high blood sugar levels.

2 Aug 2009

Race/ethnicity, income and education associated with sugar consumption

The intake of added sugars in the United States is excessive, estimated by the US Department of Agriculture in 1999-2002 as 17% of calories a day. Consuming foods with added sugars displaces nutrient-dense foods in the diet.

2 Aug 2009

Tarceva shown to extend survival in advanced non-small cell lung cancer when used after initial chemo

OSI Pharmaceuticals, Inc. has announced further results from the Phase III SATURN study showing that Tarceva® (erlotinib) extended the survival of patients with advanced non-small cell lung cancer (NSCLC) when used as single agent, maintenance therapy in patients who did not progress following first-line treatment with platinum-based chemotherapy.

2 Aug 2009

Ethical ramifications of H1N1 vaccine priority groups

Pregnant women are among the groups that should receive H1N1 (swine) flu vaccinations this fall, according to the Advisory Committee on Immunization Practices panel whose recommendations are generally accepted by the Centers for Disease Control and Prevention.

31 Jul 2009

IPS examines legislative measures to fight HIV/AIDS

Inter Press Service examines several civil society organizations' argument that legislative measures aimed at fighting HIV/AIDS, "hurt more" than they "help." There are 58 countries with laws in place to "prosecute HIV transmission" and 33 others where such legislation is being considered, according to the International Planned Parenthood Federation.

31 Jul 2009

Lancet examines leishmaniasis in east Africa

A Lancet world report examines the growing threat of visceral leishmaniasis on populations in eastern Africa. Each year, the parasitic disease affects around 500,000 people worldwide, killing roughly 50,000. Though "[t]wo-thirds of [leishmaniasis] patients are in southeast Asia … the second largest foci is east Africa: perhaps as many as 40,000 cases every year, and incidence is on the rise," according to the article.

31 Jul 2009

CNN examines efforts to prevent nursing shortages in Malawi

CNN examines Malawi's efforts to address its shortage of nurses. Though in the past, health workers "have been lured abroad by the promise of higher wages and better working conditions," the country has succeeded in putting a stop to "its crippling brain drain of nurses" by expanding "educational opportunities for nurses at all levels" and by "paying modestly more money," CNN writes.

31 Jul 2009

U.S. decision on use of adjuvants could reduce world supply of H1N1 vaccine, says Lancet editorial

"A U.S. plan to rely on swine flu vaccines without ingredients to stretch the supply [known as adjuvants] would reduce the number of available shots just when other countries need them most, the British journal Lancet said in an editorial," Bloomberg writes.

31 Jul 2009

U.N. program has little effect in reducing deaths among children in Bangladesh, study finds

"The U.N. unveiled a multimillion dollar strategy a dozen years ago to save children worldwide, but a new [Lancet] study has found the program had surprisingly little effect in Bangladesh, one of the world's poorest countries," the Associated Press reports.

31 Jul 2009

Senate Finance Committee won't vote on reform bill before recess

Just one day after it appeared negotiators were on the cusp of a deal, Senate Finance Committee Chairman Sen. Max Baucus said Thursday that his committee will not vote on a health reform bill before the August recess, Politico reports.

31 Jul 2009

Blue Dogs' bargain blasted as centrists' role questioned

Kaiser Health News reports that an agreement by House Democrats with fiscally conservative Blue Dog Democrats has a cadre of detractors, including "state officials worried about increased Medicaid costs and liberal lawmakers upset about a proposed reduction in subsidies for low-income families to buy insurance."

31 Jul 2009

House energy and commerce Democrats vote for public plan, Republicans balk

"The House Energy and Commerce Committee resumed work Thursday on major health care legislation, voting to establish a government-run health insurance plan, as top Republicans stepped up their criticism of the ambitious legislation," The New York Times reports.

31 Jul 2009

August health reform forecast: high probability of hot debate, crowded airwaves

"House Speaker Nancy Pelosi is trying to unite her divided caucus around a common enemy - the health insurance industry - previewing an August recess line of attack by Democrats trying to maintain momentum on health care reform," Politico reports.

31 Jul 2009

Hospitals treating wealthy foreigners to assure cash flows

International patients spending $3 billion a year on care in the United States are helping fund a gap for hospitals waiting with bated breath to see how health care reform will affect them, Marketplace reports.

31 Jul 2009